Key result
Trial protocol evaluates valsartan and fluvastatin as upstream therapies for hypertensive patients with non-permanent AF.
Answers are grounded in this paper and cite their sources.
Informed consent statement.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2015) studied this question. Valsartan and fluvastatin are being evaluated as upstream therapeutic strategies for hypertensive patients with non-permanent atrial fibrillation in a randomized controlled trial protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: